We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Tumor destruction using electrochemotherapy followed by CpG oligodeoxynucleotide injection induces distant tumor responses.
- Authors
Roux, Stephan; Bernat, Claire; Al-Sakere, Bassim; Ghiringhelli, François; Opolon, Paule; Carpentier, Antoine F.; Zitvogel, Laurence; Mir, Lluis M.; Robert, Caroline
- Abstract
Electrochemotherapy (ECT) is an effective local therapy of human cutaneous cancers but has no effect on distant untreated tumors. We addressed whether tumor-associated antigens released after ECT could induce an efficient systemic immunity when associated with an appropriate immunoadjuvant. We first studied the nature of the cellular recruitment and the expression of various toll-like receptors (TLRs) in tumors treated by ECT. We found that ECT induced a massive recruitment of CD11c and CD11b positive cells in the tumors and a strong increase of TLR9 expression. We then tested antitumor effects of the combination: ECT followed by TLR-9 ligands, CpG oligodeoxynucleotides (CpG ODN), in three murine tumor models. We found that this combination triggered both potent local synergistic antitumor effects, on the ipsi-lateral ECT-treated tumor, and more interestingly, a systemic antitumor response on the contra-lateral untreated tumor, in the three models. The systemic protection was T-cell dependent as it was not observed in nude littermates. The combination induced tumor-specific T cell effectors in the tumor-draining lymph nodes and in the spleen which secreted significantly more gamma-interferon upon activation than with ECT or CpG ODN alone. Our data show that ECT and CpG ODN synergize and induce a significant increase of the local effect and a systemic T-dependent antitumor response. Such combination constitutes a potential innovative vaccination strategy using in situ tumor-associated antigens that could eventually be translated into the clinic.
- Subjects
DRUG therapy; TUMORS; TUMOR antigens; IMMUNITY; IMMUNE response; IMMUNOLOGY
- Publication
Cancer Immunology, Immunotherapy, 2008, Vol 57, Issue 9, p1291
- ISSN
0340-7004
- Publication type
Article
- DOI
10.1007/s00262-008-0462-0